The Use of Crizotinib in Sclerosing Epithelioid Fibrosarcoma with ALK Mutation: A Case Report.Published in:Case Reports in Oncology, 2023, v. 16, n. 1, p. 746, doi. 10.1159/000532099By:Badran, Ahmed;Steele, Clara;Alquaydheb, Hisham;Ba Theeb, Ahmed;Bawazir, Abdulmalek;Elshenawy, Mahmoud A.;Atallah, Jean PaulPublication type:Article